N@N

Market Maker Surveillance Report. REGN, MOBI, CRME, CLUB, SHOR, STVI, Winning Stocks With Lowest Price Friction For Wednesday,

April 27, 2011 / M2 PRESSWIRE / BUYINS.NET / www.buyins.net, announced today its proprietary Market Maker Friction Factor Report for Wednesday. Since October 2008 market makers are now required to be on the bid as much as they are on the offer and for like amounts of stock. This Fair Market Making Requirement is designed to prevent market makers from manipulating stock prices. On Wednesday there were 2695 companies with "abnormal" market making, 3204 companies with positive Friction Factors and 1909 companies with negative Friction Factors. Here is a list of the top companies with the largest percentage gain per share Wednesday and low price friction (bullish). This means that there was more buying than selling in the stocks and their stock prices rose faster with less Friction. REGENERON PHARMACEUTICALS (NASDAQ:REGN), SKY-MOBI LTD-SP ADR (NASDAQ:MOBI), CARDIOME PHARMA CORP (NASDAQ:CRME), TOWN SPORTS INTERNATIONAL (NASDAQ:CLUB), SHORETEL INC (NASDAQ:SHOR), SNAP INTERACTIVE INC (OTCBB:STVI). To access Friction Factor, Naked Short Data and SqueezeTrigger Prices on all stocks please visit http://www.buyins.net .

Market Maker Friction Factor is shown in the chart below:

     Symbol     Change       Percent      Buy Volume      Buy %%       Sell Volume     Sell %%      Net Volume      Friction
     REGN       $15.160      29.08%       4,786,198       50.03%       4,446,327       46.48%       339,871         224     
     MOBI       $3.030       17.46%       953,584         51.23%       875,957         47.06%       77,627          256     
     CRME       $0.940       21.32%       665,419         56.00%       522,646         43.99%       142,773         1,519   
     CLUB       $1.140       21.31%       196,548         64.22%       108,593         35.48%       87,955          772     
     SHOR       $1.560       16.96%       1,416,157       52.42%       1,271,637       47.07%       144,520         926     
     STVI       $0.470       18.65%       245,746         29.34%       131,170         15.66%       114,576         2,438   

Analysis of the Friction Factor chart above shows that each of the six stocks mentioned above have high net buy volumes (buy volume, sell volume) and low price friction in their stocks. The Friction Factor displays how many more shares of buying than selling are required to move a stock higher by one cent or how many more shares of selling than buying moves a stock lower by 1 cent.

For example, the chart above shows REGN with a dollar gain Wednesday of $15.16000 and a Friction Factor of 224 shares. That means that it only took 224 more shares of buying than selling to move REGN higher by one penny. The Market Makers are currently allowing the stock to rise quickly (low friction). The combination of low friction and positive market direction can drive prices higher much faster than normal.

REGENERON PHARMACEUTICALS (NASDAQ:REGN) - Regeneron Pharmaceuticals, Inc., a biopharmaceutical company, discovers, develops, and commercializes pharmaceutical products for the treatment of serious medical conditions in the United States. The companys commercial product includes ARCALYST (rilonacept) injection for subcutaneous use for the treatment of cryopyrin-associated periodic syndromes, including familial cold auto-inflammatory syndrome and muckle-wells syndrome in adults and children. Its products under Phase III clinical trials include Rilonacept for the prevention and treatment of gout-related flares; VEGF Trap-Eye for eye diseases using intraocular delivery; and Aflibercept for the treatment of oncology. The companys earlier stage clinical programs REGN475, an antibody to nerve growth factor, which is being developed for the treatment of pain; REGN88, an antibody to the interleukin-6 receptor, which is developed in rheumatoid arthritis; REGN421, an antibody to delta-like ligand-4, for the treatment of oncology; REGN727, an antibody to proprotein convertase substilisin/kexin type 9, which is developed for low density lipoprotein cholesterol reduction; and REGN668, an antibody to the interleukin-4 receptor for certain allergic and immune conditions. Regeneron Pharmaceuticals also conducts other preclinical research programs in the areas of oncology and angiogenesis, ophthalmology, metabolic and related diseases, muscle diseases and disorders, inflammation and immune diseases, bone and cartilage, pain, cardiovascular diseases, and infectious diseases. The company has strategic collaboration with sanofi-aventis Group to discover, develop, and commercialize fully human monoclonal antibodies; and Bayer HealthCare LLC for the development of the VEGF-Trap-Eye. Regeneron Pharmaceuticals was founded in 1988 and is based in Tarrytown, New York.

SKY-MOBI LTD-SP ADR (NASDAQ:MOBI) - Sky-mobi Limited operates the mobile application store in China. The company works with handset companies to pre-install its Maopao mobile application store on handsets and with content developers to provide users with applications and content titles. Users of its Maopao store can browse, download, and purchase a range of applications and content, such as single-player games, mobile music, and books. Its Maopao store enables mobile applications and content to be downloaded and run on various mobile handsets with different hardware and operating system configurations. The company also operates a mobile social network community in China, the Maopao Community, where it offers localized mobile social games, as well as applications and content with social network functions to its registered members. Sky-mobi Limited owns proprietary mobile application technology in the cloud computing, the MRP format, and SDK development environment. The company was formerly known as Profit Star Limited and changed its name to Sky-Mobi Limited in October 2010. The company was incorporated in 2007 and is based in Hangzhou, the Peoples Republic of China.

CARDIOME PHARMA CORP (NASDAQ:CRME) - Cardiome Pharma Corp., a life sciences company, focuses on developing drugs to treat or prevent cardiovascular diseases. The companys product pipeline primarily includes Vernakalant (iv), which is in Phase III (ACT 5) clinical trials for the treatment of atrial fibrillation; Vernakalant (oral) that completed Phase IIa clinical trials and Phase IIb clinical trials for the treatment of atrial fibrillation; and GED-aPC, which completed Phase I clinical trials for the treatment of multiple disease states. It has collaboration and license agreements with Merck & Co., Inc. for the development and commercialization of vernakalant; and Astellas Pharma US, Inc. to develop, make, and sell injectable formulations of vernakalant in North America. The company was formerly known as Nortran Pharmaceuticals Inc. and changed its name to Cardiome Pharma Corp. in June 2001. Cardiome Pharma Corp. was founded in 1986 and is headquartered in Vancouver, Canada.

TOWN SPORTS INTERNATIONAL (NASDAQ:CLUB) - Town Sports International Holdings, Inc. and its subsidiaries own and operate fitness clubs in the Northeast and the Mid-Atlantic regions of the United States, as well as in Switzerland. Its facilities include cardiovascular equipment; free weight and strength equipment; group exercise and cycling studios; the entertainment system network; and locker rooms, including shower facilities, towel service, and other amenities, such as saunas, babysitting, and a pro-shop. The company also provides facilities, including swimming pools and racquet, and basketball courts; and programs, which include small group training, childrens programs, and other programs targeting adult members. As of December 31, 2009, it operated 161 fitness clubs comprising 109 New York Sports Clubs, 25 Boston Sports Clubs, 18 Washington Sports Clubs (2 of which are partly-owned), 6 Philadelphia Sports Clubs, and 3 clubs located in Switzerland. The company is based in New York, New York.

SHORETEL INC (NASDAQ:SHOR) - ShoreTel, Inc., together with its subsidiaries, provides Internet protocol (IP) telecommunications systems for enterprises in the United States. The companys systems are based on its distributed software architecture and switch-based hardware platform that enable a single system to serve multi-site enterprises. Its solutions comprise ShoreGear switches, ShorePhone IP phones, and ShoreWare software applications. The company also provides post-contractual support, training, system design and installation, and professional services. It serves small, medium, and large companies, as well as public institutions in various markets, including the professional services, financial services, government, education, healthcare, manufacturing, non-profit organization, and technology. The company sells its systems through a network of 700 channel partners, including distributors. ShoreTel, Inc. was founded in 1996 and is headquartered in Sunnyvale, California.

SNAP INTERACTIVE INC (OTCBB:STVI) - Snap Interactive, Inc. provides online dating applications for social networking Websites and mobile platforms. The company develops dating applications built on Facebook, MySpace, Bebo, and Hi5 platforms. Its applications include Are You Interested, a dating application; Are You Interested on the iPhone, a mobile dating application; AreYouInterested.com, an online dating Website; Meet New People, an application that allows users to flirt with each other by messaging online and post when they are free to hang out; and Flirt With Me, a fun dating application. The company was formerly known as eTwine Holdings, Inc. and changed its name to Snap Interactive, Inc. in December 2007 to reflect its shifting focus towards producing dating applications for social networking Websites. The company was founded in 2004 and is headquartered in New York, New York.

About BUYINS.NET

BUYINS.NET, www.buyins.net , monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:

REGULATORY & COMPLIANCE NEWS

Friction Factor -- market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements"

RegSHO Naked Shorts -- tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO

INVESTMENTS & TRADING

SqueezeTrigger -- 29 billion cell database tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock.

Earnings Edge -- predicts probability, price move and length of move before and after all US stock earnings reports.

Seasonality -- predicts probability, price move and length of move based on exact time of year for all US stocks.

Group Trader -- tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups.

Pattern Scan -- automates tracking of every technical pattern and predicts time and size of move in all stocks.

GATS (Global Automated Trading System) -- tracks all known trading strategies and qualifies and quantifies which are working best in real time.

DISCLAIMER:

BUYINS.NET is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. BUYINS.NET has not been compensated by any of the above mentioned companies. Past performance is not indicative of future results. Please visit our web site, www.buyins.net , for complete risks and disclosures.

Contact:

BUYINS.NET Thomas Ronk 800-715-9999 tom@buyins.net www.buyins.net